How Hyperbaric Oxygen Therapy Accelerates Wound Healing

Breathing Pure Oxygen Under Pressure to Heal From the Inside

At sea level, the air we breathe contains 21% oxygen at 1 atmosphere absolute (ATA) of pressure. During hyperbaric oxygen therapy (HBOT), a patient breathes 100% oxygen inside a pressurized chamber at 2 to 3 ATA. Under these conditions, blood plasma carries roughly 15 to 20 times more dissolved oxygen than normal—enough to sustain tissues even without hemoglobin. This oxygen surplus triggers a cascade of healing responses: new blood vessel growth, reduced inflammation, enhanced white blood cell killing power, and accelerated tissue repair. HBOT has been FDA-approved for 14 specific conditions since the 1970s, yet it remains one of the most debated treatments in modern medicine.

The Physics Behind the Therapy

HBOT's mechanism rests on Henry's Law: the amount of gas dissolved in a liquid is proportional to the pressure of that gas above the liquid. At 3 ATA breathing 100% oxygen, arterial oxygen partial pressure rises from the normal 100 mmHg to approximately 2,000 mmHg. Tissue oxygen levels increase by a factor of 10 or more.

The increased diffusion distance is critical for chronic wounds. Damaged tissue around a wound has compromised blood supply—capillaries are destroyed, and oxygen cannot reach the wound bed. HBOT pushes oxygen through plasma diffusion rather than relying on blood vessel delivery.

FDA-Approved Indications

The Undersea and Hyperbaric Medical Society (UHMS) and the FDA recognize 14 conditions for which HBOT has sufficient evidence of benefit:

• Decompression sickness ("the bends")—the original and most clear-cut indication
• Arterial gas embolism
• Carbon monoxide poisoning (reduces half-life of carboxyhemoglobin from 5 hours to 23 minutes)
• Diabetic foot ulcers (Wagner grade 3 or higher, failing standard therapy)
• Chronic refractory osteomyelitis (bone infection not responding to antibiotics and surgery)
• Delayed radiation injury (soft tissue and bone necrosis following cancer radiation therapy)
• Compromised skin grafts and flaps
• Crush injuries and acute traumatic ischemia
• Necrotizing soft tissue infections ("flesh-eating" bacteria—adjunct to surgery and antibiotics)
• Severe anemia when transfusion is not an option
• Gas gangrene (Clostridial myonecrosis)
• Thermal burns
• Intracranial abscess
• Acute peripheral arterial insufficiency

Chamber Types and Session Protocol

HBOT is delivered in two types of chambers, each with distinct advantages and limitations.

A standard treatment session lasts 90 to 120 minutes at pressure. Patients descend (compress) over 10–15 minutes, breathe oxygen at treatment depth for 60–90 minutes (with periodic air breaks to reduce oxygen toxicity risk), then ascend (decompress) over 10–15 minutes. Treatment courses range from 1 session (acute gas embolism) to 40–60 sessions (radiation injury, chronic wounds).

How HBOT Heals Chronic Wounds

Diabetic foot ulcers affect approximately 15% of diabetics during their lifetime, and they precede 84% of diabetes-related lower-limb amputations. HBOT addresses several mechanisms simultaneously:

• Angiogenesis: Hyperoxia followed by return to normal oxygen creates a cyclical stimulus that triggers vascular endothelial growth factor (VEGF) release, promoting new capillary formation in wound margins
• Bacterial killing: Oxygen-dependent white blood cell killing mechanisms (the oxidative burst) require tissue pO₂ above 40 mmHg—many chronic wounds fall below this threshold
• Collagen synthesis: Fibroblasts require oxygen to produce collagen, the structural protein of healing tissue. Collagen production plateaus when tissue pO₂ is inadequate
• Biofilm disruption: HBOT enhances antibiotic penetration into bacterial biofilms that protect chronic wound infections

A 2016 Cochrane review found that HBOT increased the likelihood of diabetic foot ulcer healing at six months compared to standard care, though the evidence quality was graded as low to moderate.

Decompression Sickness: The Classic Indication

Scuba divers who ascend too quickly develop decompression sickness when dissolved nitrogen forms bubbles in blood and tissues—causing joint pain ("the bends"), neurological symptoms, and potentially death. HBOT treats this by physically compressing the gas bubbles (Boyle's Law) and accelerating nitrogen elimination through the lungs. Treatment protocols (U.S. Navy Treatment Table 6 is standard) can last five to eight hours and are initiated as emergency medicine. Outcomes are best when treatment begins within hours of symptom onset.

The Off-Label Controversy

HBOT's biggest controversy centers on conditions outside the 14 FDA-approved indications. Clinics—particularly those marketing directly to consumers—promote HBOT for autism, traumatic brain injury (TBI), cerebral palsy, anti-aging, athletic recovery, and long COVID. The evidence base for these applications ranges from thin to nonexistent.

• TBI: a large VA-funded randomized trial found no significant difference between HBOT and sham treatment for persistent post-concussion symptoms in military veterans
• Autism: a 2009 multicenter trial showed modest behavioral improvements, but critics noted the sham group (slightly pressurized air) also improved, suggesting a placebo effect
• Long COVID: an Israeli trial in 2022 reported cognitive improvements, but sample size was small and replication is needed
• Anti-aging: a 2020 Israeli study reported telomere lengthening after 60 HBOT sessions, but the clinical significance is unknown

Off-label HBOT sessions typically cost $150–$300 per session out of pocket, and treatment courses of 40–80 sessions are common—totaling $6,000 to $24,000. Insurance does not cover off-label use. The gap between patient hope and scientific evidence creates an ethical tension that the field continues to navigate.

Risks and Side Effects

HBOT is generally safe when administered by trained personnel in accredited facilities. The most common side effect is middle ear barotrauma (ear pain during pressurization), occurring in 2%–10% of patients. Oxygen toxicity seizures occur in roughly 1 in 10,000 treatments. Rare complications include sinus pain, temporary myopia (lens shape changes under pressure, resolving within weeks), and claustrophobia. Fire is the most serious hazard—100% oxygen environments are extremely flammable, and chamber fires, though rare, have been fatal.

This article is for informational purposes only. Consult a qualified professional.